NCT04375878
OPTION 2: A Trial to Assess the Safety and Efficacy of MS1819 in Enteric Capsules in Patients With Cystic Fibrosis No drug interventions treatment 2 completed NCT03746483
OPTION: A Trial to Assess the Safety & Efficacy of MS1819 in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis No drug interventions treatment 2 completed NCT04315311
Study Of Effects Of Oral CREON Capsules In Adult Participants With Exocrine Pancreatic Insufficiency Not Due To Cystic Fibrosis, Chronic Pancreatitis, Pancreatectomy, Or Pancreatic Cancer treatment 4 withdrawn NCT03859869
A Study of Creon (Pancrelipase) in Resected and Non-resected Pancreatic Cancer Participants With Exocrine Pancreatic Insufficiency (EPI) treatment 4 terminated NCT05082051
Oral CDX-7108 in Healthy Adults and EPI Subjects No drug interventions treatment 1 completed NCT05719311
Study to Assess an Enteric Microgranule Formulation of Adrulipase in Patients With Cystic Fibrosis No drug interventions treatment 2 completed NCT00500084
Phase III ALTU-135 CP Safety Trial treatment 3 terminated NCT06581653
Medication Adherence to Phone-supervised Pancreatic Enzyme Replacement Therapy No drug interventions health_services_research Not Available recruiting NCT04966897
Assessment of a PERT-free Nutritional Therapeutic Delivery System for Cystic Fibrosis No drug interventions treatment Not Available completed NCT00775528
Study Investigating a Delayed-Release Pancrelipase in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis treatment 3 completed NCT00788593
A Randomized, Double-Blind, Dose Response-Control, Crossover Study to Evaluate the Safety and Efficacy of Two Doses of EUR-1008 (APT-1008) in Chronic Pancreatitis (CP) Participants With Exocrine Pancreatic Insufficiency (EPI) treatment 3 completed NCT00449878
Liprotamase Efficacy Trial in Patients With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency treatment 3 completed NCT04548778
BÜHLMANN fPELA in the Diagnosis of Exocrine Pancreatic Insufficiency No drug interventions Not Available Not Available recruiting NCT05804409
Screening for Pancreatic Exocrine Insufficieny in Metabolic Associated Fatty Liver Disease Patients No drug interventions Not Available Not Available not_yet_recruiting NCT05132309
Intestinal Microbiota Composition in Patients With Chronic Pancreatitis and Pancreatic Exocrine Insufficiency No drug interventions Not Available Not Available completed NCT00559052
An Open-Label Study to Evaluate the Intraduodenal Delivery of Enzymes From Administration of VIOKASE16 in Exocrine Pancreatic Insufficiency (EPI) No drug interventions diagnostic 2 completed NCT02175459
Investigating Predictive Factors of Diabetes Occurence After Duodenalpancreatectomy No drug interventions Not Available Not Available recruiting NCT00662675
A Study of the Efficacy and Tolerability of Pancrelipase Microtablet (MT) Capsules for the Treatment of Cystic Fibrosis-dependent Exocrine Pancreatic Insufficiency treatment 3 completed NCT05480241
Exocrine Pancreatic Insufficiency After Acute Pancreatitis and Pancreatic Enzyme Replacement Therapy No drug interventions treatment Not Available recruiting NCT00408317
Safety and Efficacy Study of ULTRASE® MT20 in Participants With Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (PI) treatment 3 completed NCT01430234
Enzyme Suppletion in Exocrine Pancreatic Dysfunction treatment 4 completed NCT03407534
Detection of Exocrine Pancreatic Insufficiency in Patients With Diarrhea and Bloating No drug interventions Not Available Not Available completed NCT01424696
Baby Observational and Nutritional Study No drug interventions Not Available Not Available completed NCT04306939
Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study No drug interventions Not Available Not Available suspended NCT00690820
Study Investigating a Delayed-Release Pancrelipase in Patients With Pancreatic Exocrine Insufficiency (PEI) Due to Cystic Fibrosis (CF) treatment 3 completed NCT06119880
The Effect of PERT on Patients Undergoing Pancreaticoduodenectomy treatment 4 recruiting NCT02563080
Pancreatic Exocrine Insufficiency in Acute Pancreatitis No drug interventions Not Available Not Available completed NCT00449904
Open-Label Phase III Long-Term Safety Trial of Liprotamase treatment 3 completed NCT06278272
AI Evaluation of Pancreatic Exocrine Insufficiency in CP Patients No drug interventions Not Available Not Available completed NCT05791110
PE-1 in the Diagnosis of Pancreatic Exocrine Insufficiency No drug interventions diagnostic Not Available completed NCT02734810
SIMPLICITY: Studying Impacts on Malabsorption With Liprotamase in Cystic Fibrosis No drug interventions treatment 3 completed NCT00414908
A Study to Investigate the Effect of Delayed Release Pancrelipase on Maldigestion in Patients With Exocrine Pancreatic Insufficiency Due to Chronic Pancreatitis and Pancreatectomy treatment 3 completed NCT04690738
Role of Pancreatic Exocrine Secretion in Weight Gain After Pancreas Transplantation No drug interventions Not Available Not Available recruiting NCT01327703
Control of Steatorrhea in Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency No drug interventions treatment 4 completed NCT03051490
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment No drug interventions treatment 3 unknown_status NCT00559364
Safety and Efficacy Study of Viokase® 16 for the Correction of Steatorrhea treatment 3 completed NCT02823964
EASY: Extended Access to Sollpura Over Years No drug interventions treatment 4 completed NCT05980221
The Development of a Metabolomic Test to Diagnose and Quantify Pancreatic Exocrine Insufficiency (The DETECTION Study) No drug interventions diagnostic Not Available recruiting NCT00676702
A Study of the Enzyme Activity and Safety of Pancrelipase in Patients With Severe Exocrine Pancreatic Insufficiency (EPI) Not Available 1 completed NCT02279498
SOLUTION: Study of Oral Liprotamase Unit-Matched Therapy Of Non-Porcine Origin in Patients With Cystic Fibrosis No drug interventions treatment 3 completed NCT05261997
Endotherapy for Painless Chronic Pancreatitis treatment Not Available unknown_status NCT00743483
Efficacy of Bucelipase Alfa (BSSL) in Patients With Cystic Fibrosis and Pancreatic Insufficiency treatment 2 completed NCT05112328
The Effects of Pancreatic Enzyme Supplementation in Critically Ill Patients on Enteral Feeding No drug interventions supportive_care Not Available recruiting NCT02598128
Safety, Tolerability and Fat Absorption Using Enteral Feeding In-line Enzyme Cartridge (Relizorb) No drug interventions treatment Not Available completed NCT05385211
Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and Exocrine Pancreatic Dysfunction in Type 1 Diabetes No drug interventions Not Available Not Available completed NCT06052293
Phase 1 Study to Assess Safety and Efficacy of ANG003 No drug interventions treatment 1 completed NCT01131507
PR-018: An Open-Label, Safety Extension of Study PR-011 treatment 4 completed NCT02370537
A Study to Investigate How Common Pancreatic Exocrine Insufficiency (PEI) is in Patients With Type 2 Diabetes and Also to Investigate the Uptake of a Single Dose of EPANOVA® or OMACOR® in Patients With Different Degrees of PEI treatment 2 completed NCT06477159
Pancreatic Enzyme Replacement Therapy for Acute Pancreatitis-Associated Exocrine Pancreatic Insufficiency treatment 4 recruiting NCT00663975
Open Label Safety Study of DCI-1020 in Pediatric Cystic Fibrosis (CF) Patients No drug interventions treatment Not Available withdrawn NCT00749099
Bioavailability of Pancreatic Enzymes in the Human Upper Intestine (Duodenum and Jejunum) Not Available Not Available terminated NCT01100606
A Study to Evaluate the Mode of Administration and Safety of EUR-1008 (APT-1008) in Infants 1 to 12 Months of Age treatment 4 completed NCT04112836
Pancreatic Cancer Malnutrition and Pancreatic Exocrine Insufficiency in the Course of Chemotherapy in Unresectable Pancreatic Cancer No drug interventions Not Available Not Available unknown_status NCT01427725
Special Investigation of LipaCreon on Long-term Use in Patients With Pancreatic Exocrine Insufficiency No drug interventions Not Available Not Available completed NCT01747330
Evaluation of Safety and Tolerability of Creon Micro in Children Younger Than Four Years With Pancreatic Exocrine Insufficiency treatment 3 completed NCT05244174
Impact of Pancreatic Endoscopic Drainage on Exocrine Pancreatic Function in Unresectable Pancreatic Cancer No drug interventions treatment Not Available recruiting NCT05450627
Registry of Pancreatic Exocrine Insufficiency. No drug interventions Not Available Not Available unknown_status NCT00297167
Study to Evaluate the Safety and Efficacy of EUR-1008 (APT-1008) Pancreatic Enzyme Product in Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency treatment 3 completed NCT06006312
Establishment and Clinical Application of Pancreatic Endocrine and Exocrine Function Tests No drug interventions Not Available Not Available recruiting NCT01427712
Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis Not Available Not Available completed NCT00981214
Study of Pancreatic Enzyme Product in Pediatric Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency treatment 3 completed NCT00744250
Intraduodenal Aspiration Study to Assess the Bioavailability of Oral Pancrecarb® Compared to Placebo Control supportive_care 4 terminated NCT03236038
Prevalence of Exocrine Pancreatic Insufficiency in Patients With Decompensated Cirrhosis No drug interventions Not Available Not Available completed